This article is more than 5 years old. Information may no longer be current.
Chugh named head of Cedars-Sinai Heart Institute
Click Here to Manage Email Alerts
Sumeet S. Chugh, MD, previously an associate professor of medicine at Oregon Health and Science University and a leader in research on sudden cardiac arrest, has been named associate director of the Cedars-Sinai Heart Institute.
Chugh was previously the director of the cardiac arrhythmia center at Oregon Health and Science Univeristy in Portland, where he was section chief of clinical cardiac electrophysiology and associate professor of medicine.
Chugh also led the Oregon Sudden Unexpected Death Study, a population study involving 16 hospitals, beginning in 2002.
He is board certified in CVD disease and clinical cardiac electrophysiology and has experience in diagnostic procedures, the use of pacemakers, defibrillators, biventricular devices and radiofrequency ablation techniques.
|
|
“Dr. Chugh is respected internationally as a brilliant researcher with unsurpassed clinical skills,” Eduardo Marban, MD, PhD, director of the Cedars-Sinai Heart Institute, said in a press release. “This combination gives him the rare ability to provide excellent, compassionate patient care while producing landmark research that is changing the way we understand and treat heart rhythm abnormalities.”
Chugh has published over 100 articles and abstracts, is an article reviewer for 13 medical and scientific journals and is a member of the editorial board of the Journal of Cardiovascular Pharmacology and Therapeutics. He is also a charter member of the Electrical Signaling, Ion Transport and Arrhythmias Study Section, Center for Scientific Review for the National Institutes of Health.
He received his medical degree with honors from the Government Medical College, Patiala, in Punjab, India and served as a research associated at Tufts New England Medical Center. Chugh completed his medical fellowship in cardiology at the University of Minnesota in Minneapolis and a fellowship in clinical cardiac electrophysiology at Mayo Clinic in Rochester, Minn.
Ohio State University heart program names first Schottenstein laureate
|
|
Pascal Goldschmidt, MD, senior vice president for medical affairs and dean of the University of Miami Leonard M. Miller School of Medicine, was selected by the Ohio State University Heart and Vascular Center as the inaugural recipient of the Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
Goldschmidt received the award at a ceremony in Columbus on October 27. The award is given biennially to an international leader in cardiovascular medicine, cardiothoracic surgery or the basic sciences of molecular or cellular cardiology. Goldschmidt, as the Laureate, received a $100,000 honorarium.
“Dr. Goldschimdt is an outstanding choice for the first Schottenstein Prize,” Thomas Ryan, MD, director of Ohio State’s Heart and Vascular Center, said in a press release. “He has excelled at fundamental cardiovascular research while maintaining a reputation as an outstanding clinician, teacher and administrator.”
Goldschmidt received his medical degree from the Universite Libre dr Bruxelles in Brussels. He went on to complete his residency and fellowship training at Erasme Academic Hospital in Brussels and at Johns Hopkins University. Goldschmidt served as an associate professor of medicine at Johns Hopkins until 1997, when he transferred to the Ohio State University College of Medicine and Public Health, where he served as director of cardiology from 1997 to 2000. In 2000, Goldschmidt transferred to Duke University Medical Center in Raleigh to serve as the chairman of the department of medicine.
Barry London, MD, PHD, honored for research in sudden cardiac death
|
|
The National Institutes of Health recently honored Barry London, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine, with one of 16 National Institutes of Health Pioneer Awards for research into sudden cardiac death.
London will receive $2.5 million in direct costs from the NIH to conduct novel experiments designed to help identify patients at high risk for sudden cardiac arrest. With the award, London and colleagues will work on developing techniques to image electrical activity in the heart. One project involves adapting two-dimensional echocardiography to detect electrical activity of the heart in real time. London and colleagues will develop a modified adult stem cell implant to detect nervous system activity affecting the heart in the second project.
London will be collaborating with Flordeliza Villanueva, MD, an associate professor of medicine at the University of Pittsburgh School of Medicine, who will be developing a novel electrically sensitive microbubble contrast agent that will help image electrical activity within the heart muscle.
“These programs are central elements of NIH efforts to encourage and fund especially novel investigator-initiated research, even if it might carry a greater-than-usual risk of not succeeding,” Elias A. Zerhouni, MD, director of the NIH, said in a press release. “These highly creative researchers are tackling important scientific challenges with bold ideas and inventive technologies that promise to break through barriers and radically shift our understanding.”
Shah receives James B. Herrick Award for Scientific Achievement
|
|
The American Heart Association Council on Clinical Cardiology has awarded the James B. Herrick Award for Scientific Achievement to Prediman K. Shah, MD, director of the division of cardiology at Cedars-Sinai Heart Institute.
The Herrick award, which is given each year at the annual AHA Scientific Sessions, is awarded for scientific achievements that have contributed profoundly to the advancement and practice of clinical cardiology.
Shah is credited with many scientific contributions in the areas of atherosclerosis, coronary artery disease and acute coronary syndromes. Among his accomplishments, Shah collaborated with William Ganz, MD, to provide the first clot-dissolving therapy to treat MIs in humans. Shah also led pioneering research related to the mutant gene apo A-1 Milano, which has protective effects against atherosclerosis. Shah has published over 550 scientific papers, abstracts book reviews and chapters and has edited or co-edited several books, including a cardiology textbook. Shah is also a member of the editorial board of numerous peer-reviewed cardiology journals.
The lecture given by Shah upon receiving the Herrick Award, entitled “Vaccine for Atherosclerosis: Chasing the Holy Grail,” was published in October in the Scientific Sessions supplement to Circulation.